Justify’s Valentine Candy Dominates Oaklawn’s Advent

Valentine Candy (Justify) put a sweet punctuation to his year with a dominant display in the Advent S. on Oaklawn's opening day.

Victorious against a well-met field of Saratoga maidens in July, the chestnut tired badly in the GI Hopeful S. after a round of bumper cars soon after the break took him off the pace. He resurfaced at Keeneland in October with two starts–a second against first-level optional claimers on the seventh and then running third Oct. 28 in the Bowman Mill S.

Sent away at 9-5 in good order and able to be part of the pace pressure on the frontrunner, he swung into the backstretch four wide and was three off the rail heading for the homeward stretch. Given his cue with Roman Vazquez sitting pretty, Valentine Candy shut down all challenges right there, kicking home 6 3/4 lengths best over 67-1 shocker Willy D's (Lookin At Lucky) and late-running Andy's Candy (Practical Joke). It was Steve Asmussen's record-extending 105th career Oaklawn stakes victory.

 

“I'm just very, if anything, relieved to see him run back to his first race,” Steve Asmussen said. “The field that he beat at Saratoga first time out–showed great quality that day. Beautiful horse; great opportunity. That's who he's supposed to be.”

Added Ramon Vazquez: “Steve didn't give me any instructions. [Valentine Candy]'s a nice horse. I just had to guide him.”

The most recent to the races for Taste Like Candy, who went runner-up in the GI Hollywood Starlet S. in her season on the track, Valentine Candy has only one other sibling of racing age. The unplaced King Happy (Street Sense) was sent to Ireland in 2018 as a yearling and the broodmare had a run of poor breeding fortunes since then until she produced the winner and recently a 2023 colt by Mitole. She was bred to Liam's Map for 2024. Click for the Equibase.com chart or VIDEO, sponsored by TVG.

ADVENT S., $150,000, Oaklawn, 12-8, 2yo, 5 1/2f, 1:04.65, ft.
1–VALENTINE CANDY, 117, c, 2, by Justify
         1st Dam: Taste Like Candy (GISP, $286,205), by Candy Ride (Arg)
         2nd Dam: My Success, by A.P. Indy
         3rd Dam: Towering Success, by Irish Tower
($250,000 Ylg '22 FTKOCT). 1ST BLACK-TYPE WIN. O-L. William & Corinne Heiligbrodt, Jackpot Farm, Whispering Oaks Farm LLC & Coteau Grove Farms LLC; B-Pine Creek LP (KY); T-Steven M. Asmussen; J-Ramon A. Vazquez. $96,038. Lifetime Record: 5-2-1-1, $195,713.
2–Willy D's, 117, c, 2, Lookin At Lucky–Boston Mine, by Mineshaft. ($60,000 2yo '23 OBSAPR). 1ST BLACK TYPE. O-Danny Brown, Charis Brenneman & Greg Compton; B-Beau Lane (KY); T-Greg Compton. $29,550.
3–Andy's Candy, 117, g, 2, Practical Joke–In Gold Blood, by My Golden Song. ($28,000 Ylg '22 TTAYRL; $84,000 2yo '23 TTAAPR). 1ST BLACK TYPE. O-JD Thoroughbreds, LLC, Joey Keith Davis & Larry J. Romero; B-Samuel Sherman (KY); T-Chris A. Hartman. $14,775.
Margins: 6 3/4, HD, 1. Odds: 1.80, 67.30, 10.10.
Also Ran: Market Street, Molly's Town, General Shipman, Frost Free, Ceepeegee, Bye Bye Liam, Drewmania, Sweet Soddy J. Scratched: Spirit's Mischief.

The post Justify’s Valentine Candy Dominates Oaklawn’s Advent appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Trainer Saldana Suspended Two Years, Fined $25k After Losing Banned Substance Arbitration Hearing

Reed Saldana, a Los Alamitos Race Course-based trainer who has been licensed since 2017, has been penalized with a two-year suspension and a $25,000 fine after a Dec. 6 Horseracing Integrity and Welfare Unit (HIWU) arbitration judgment found him to be in violation of a banned substance rule. This resulted from a positive test for diisopropylamine in one of his trainees, Ice Queen (Cairo Prince), who finished third in a Santa Anita Park starter-allowance on June 16.

Saldana is also on the hook for $12,000 toward HIWU's share of the arbitration costs that resulted from his request for a hearing.

Arbitrator Jeffrey Benz further wrote in his ruling that the connections of the mare (owner 5th Street Stables) must forfeit the disqualified $4,560 in purse winnings.

Saldana, 41, who rode as a Thoroughbred and Quarter Horse jockey between 2007 and 2011 prior to his licensure as a trainer, did not engage an attorney for his hearing and could not be reached for comment prior to deadline for this story. It is unclear if he intends to appeal the arbitration result to a Federal Trade Commission (FTC) administrative law judge, which is the next option for covered persons who wish to contest HIWU arbitration results.

Diisopropylamine is a vasodilator listed as a banned substance by HIWU, which means it can never be found in a covered racehorse. It lacks Food and Drug Administration approval.

Among Saldana's arguments presented at his Nov. 1 hearing were 1) That there was no proof he gave diisopropylamine to Ice Queen; 2) Hand sanitizer containing the prohibited substance was allegedly found and used in the test barn; 3) That there was allegedly accidental contamination by the test barn personnel; 4) That there were issues with the chain of custody during the testing process, and 5) That diisopropylamine is not a vasodilator but is a “secondary amine.”

According to the arbitrator's ruling, Saldana also submitted the following statement for consideration:

“The evidence HIWU has presented is very lacking. NO integrity, NO security, NO proof that the urine sample actually was collected properly, stored correctly or even transported securely. This urine sample MUST be INADMISSIBLE and case needs to be dismissed, to continue to proceed is just a travesty,” Saldana stated.

“We are in a country where we are innocent until proven guilty beyond a reasonable doubt and the evidence shows no proof of guilt. HIWU has failed to demonstrate Burden of Proof in this matter. HIWU has claimed that Diisopropylamine is a vasodilator when in fact by scientific proof it is not, it is an amine. These false claims and misclassification by [the Horseracing Integrity and Safety Act] of Diisopropylamine have cost me my livelihood, has caused stress, emotional, monetary and repetitional damage that I can't ever get back, to continue would just be [an] injustice,” Saldana stated.

After taking testimony from both parties, the arbitrator sided with HIWU's recommended penalties for a first-time anti-doping “presence” finding. Benz noted the key factors in his decision.

“Mr. Saldana argues that alleged errors made in collecting and analyzing Ice Queen's Sample should result in its disqualification,” Benz wrote. “His allegations are vague and unparticularized. The only specific alleged deficiency in the sample collection or custody for Ice Queen was that the Nominated Person was prevented from seeing the collection of Ice Queen's urine…

“HIWU could certainly do a better job of ensuring that the written chain of custody documentation is clearer and that the labs are required to uniformly handle chain of custody issues and documentation,” the arbitrator continued. “Having said that, Mr. Saldana's obligation was to show that the irregularities in the chain of custody that he claims were present had some effect on the outcome of the testing and he was unable to make that showing…

“With respect to his allegation that Mr. Saldana's Nominated Person was prevented from entering the testing barn to observe Ice Queen pass urine, there is no specific requirement in this regard,” Benz wrote.

“In addition, Mr. Saldana's argument that Diisopropylamine is not a vasodilator by virtue of being a secondary amine is false,” Benz wrote.

“As explained by [Dr. Lara Maxwell, a veterinarian and pharmacology professor who testified on behalf of HIWU], drugs such as Diisopropylamine can be classified both in terms of their chemical structure and their pharmacological or medicinal effects on the body.

Diisopropylamine is classified as a secondary amine due to its chemical structure. It is also considered a vasodilator due to its general pharmacological effect, i.e., causing blood vessels or open or dilate. There is nothing inconsistent about the simultaneous application of both categories, which address entirely different properties of Diisopropylamine,” Benz wrote.

“Lastly, and despite the irrelevance of a substance's effects on the Covered Horse to any argument on liability, as addressed by Dr. Maxwell, Diisopropylamine is known to have a performance-enhancing potential in horses due to its status as a vasodilator, which expands blood vessels and 'temporarily decreases the work of the heart.'

“Mr. Saldana also advanced a theory that hand sanitizer used by the [testing personnel] could have caused the positive result found in the Sample because hand sanitizers often contain the prohibited substance found here,” the arbitrator continued. “He adduced no evidence on this point, and HIWU's evidence to the contrary was compelling.”

“First, the evidence was unrefuted that the hand sanitizer used in the testing barn and all relevant areas for the Sample's journey to the refrigerator and the next day to the laboratory did not contain the Diisopropylamine,” Benz wrote.

“Second, the evidence was unrefuted that the [personnel] did not use hand sanitizer and instead used surgical gloves when collecting samples.”

“Third, HIWU's expert Dr. Maxwell testified, on an unrefuted basis, that the active ingredient in hand sanitizer is ethanol and had the horse been contaminated with hand sanitizer not only would it have required a large amount of hand sanitizer to yield the levels of Diisopropylamine found here but ethanol would also have been found in the sample and it was not found here.”

“Accordingly, the Arbitrator finds that hand sanitizer contamination was simply not possible here, and certainly not at all likely,” Benz wrote.

Saldana's career training record is 88 wins and $2.5 million in earnings from 656 starts. His last entrant was on July 1, and through the first half of 2023 Saldana posted a 7-10-9 record from 61 starters.

The Thoroughbred Regulatory Rulings database maintained by The Jockey Club shows two prior drug-related entries for Saldana: A Class 4 phenylbutazone violation in a third-place horse that resulted in a $500 fine at Santa Anita in 2022, and a Class 3 clenbuterol positive that resulted in the disqualification of a winner (but no fine) in 2020 at Los Alamitos.

Saldana's suspension, unless overruled at the FTC level, will run through Aug. 5, 2025.

The post Trainer Saldana Suspended Two Years, Fined $25k After Losing Banned Substance Arbitration Hearing appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Top Mid-Atlantic Trainer Farrior Faces Possible Suspension For Metformin

Trainer Anthony Farrior is facing a possible suspension after a horse he trained allegedly tested positive for the banned substance Metformin, according to a posting Friday on the Horseracing Integrity and Welfare Unit website.

His status is listed as “Pending: Provisional Suspension–Postponed.” Alexa Ravit, the director of communications & outreach for HIWU explained that the wording means, “that B Sample analysis has been requested following a positive A Sample result, so the implementation of the Provisional Suspension is postponed unless/until the B Sample comes back positive.”

Farrior will be allowed to train at least until the B sample is turned over to HIWU. If he is unable to beat the charges, he faces a suspension of up to two years and a fine of $25,000.

The infraction allegedly took place Nov. 5, 2023 at Laurel with the $10,000 claimer Geothermal (Gormley), who did not finish the race. According to the Equibase chart, Geothermal sustained an injury through the backstretch run, was pulled up entering the far turn and was vanned off. According to sources, the horse was euthanized, but the TDN has not been able to confirm that with its connections.

HIWU has penalized at least six trainers for Metformin positives, including Jonathan Wong, a top trainer on the Northern California circuit. In humans, Metformin is used to treat type 2 diabetes. Wong has said that he takes Metformin. The Federal Drug Administration has approved Metformin for use in humans but it is not officially approved for use in animals. Metformin has been used in horses to counteract the effects of equine metabolic syndrome, which is a disorder associated with inappropriate blood insulin levels and increased fat deposition.

Farrior's lawyer, Drew Mollica, said that to the best of his knowledge, Farrior does not take Metformin. However, he was adamant that in Farrior's case, the finding is a matter of environmental contamination.

“We are in the process of evaluating the evidence and intend to vigorously follow the evidence,” Mollica said. “We absolutely believe this is case of contamination. We are in the midst of fact finding and I think that it will be quite clear that Mr. Farrior is not liable for any wrongdoing. We are investigating any and all possibilities and eventualities. We firmly believe this is a case of contamination and when all the facts are in, it will be found that he was not liable or negligent on any manner.”

When asked what steps he would take if the B Sample came back positive, Mollica replied: “We'll cross that bridge when we get there. We ordered the B sample and are following the science. We believe that when we have all the science and the facts are in, we believe he will be exonerated.”

Farrior has been training since 2011 and has 837 wins from 3,708 starts. He is currently racing at Laurel, Charles Town and Mahoning Valley. He is leading the Charles Town standings with 134 wins on the year through Thursday. At Charles Town, he is winning with 25% of his starters.

The post Top Mid-Atlantic Trainer Farrior Faces Possible Suspension For Metformin appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Q&A With Fasig-Tipton Digital Sales Director Leif Aaron

With the largest Fasig-Tipton online auction to-date underway–counting just over 300 diverse entries in its catalogue–their December Digital Sale is making this one to remember before it closes next Tuesday, Dec. 12 at 11 a.m. ET.

Fasig-Tipton's Director of Digital Sales Leif Aaron took time out of his busy day to discuss with the TDN the numbers, the expectations, comparisons with the physical sales and a whole lot more, as the offerings unfold through the holiday weekend.

TDN: It seems like every digital sale you are announcing a record number of entries! The sheer size of the December catalogue must be a positive? What does that say about the digital climate?

Leif Aaron: Buyers and sellers are becoming increasingly comfortable with the platform. It takes time to change people's buying habits, and obviously, digital sales are very different from a live auction. Digital is being embraced by more and more owners who are conscious of costs, stress on horses and the narrow buying base at the end of marathon auctions.

TDN: The share you are offering in Flameaway (Scat Daddy), do you envisage more and more stallion shares being traded this way? Is this a growing trend? How did this opportunity develop?

Leif Aaron: I think it's actually a case of history repeating itself, many readers will remember the days when Fasig-Tipton did stallion access. In the early 2000's, Fasig-Tipton was selling seasons, shares and options online. We are happy to try things for sellers, but mainly it depends on the stallion, stud farm and the market. Just like the digital auction it must make sense for everyone involved.

I've been begging farms to save me a couple very desirable seasons to auction in February Digital. That way when they have to say 'no' to multiple breeders, they can always offer the option of 'you can buy the last one' in February online. That hasn't gained any traction as of yet and I really am puzzled as to why.

As far as how the Flameaway season came about, Chance Timm contacted me and said I have a client with a share and a LBR in a leading first-crop sire, can we go on the website? Darby Dan was kind enough to oblige and here we are.

Leif Aaron | Fasig-Tipton

TDN: Did you expect to get so many broodmares, especially just after the physical sales? Digital sales run August, October etc., so the timing has to be right, correct?

Leif Aaron: We were confident we would have a lot of breeding stock. So far on the platform we have had most of our success with broodmares and racing stock. What was a surprise to us was the number of weanlings and yearlings that were entered for this sale.

We've had some success with young horses, so I think that part of the market is currently developing online. Time of year does have to make sense in general for certain types of horses–breeding stock etc.–to sell well, but racehorses can sell no matter the time of year.

TDN: Speaking of racehorses, online seems like a perfect place to trade them (which is a very liquid market at the moment due to high purses). Could you speak about that a little? Why are racehorses maybe more suited to the digital space?

Leif Aaron: I touched on this a little bit earlier, but racehorses are in huge demand right now because of record high purses. With a digital sale, the seller can keep the horse in the barn and continue with training, while the potential buyer gets to look at the horse and look at the vetting. They are getting a lot more information than they would through the claim box.

In general, the horse racing ownership community are traders. It only makes sense for us to have a platform for those owners and trainers to buy and sell.

The post Q&A With Fasig-Tipton Digital Sales Director Leif Aaron appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights